Found: 26
Select item for more details and to access through your institution.
Raising cGMP restores proteasome function and myelination in mice with a proteotoxic neuropathy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Acetyl-CoA production from pyruvate is not necessary for preservation of myelin.
- Published in:
- Glia, 2017, v. 65, n. 10, p. 1626, doi. 10.1002/glia.23184
- By:
- Publication type:
- Article
Like a Game of Chess, Every Move Matters: The Role of Antibodies in the Myasthenia Gravis Treatment Landscape.
- Published in:
- Primary Care Companion for CNS Disorders (2155-7772), 2022, v. 24, n. 6, p. e1, doi. 10.4088/PCC.AR21018AH3C
- By:
- Publication type:
- Article
Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.892534
- By:
- Publication type:
- Article
Prohibitin 1 is essential to preserve mitochondria and myelin integrity in Schwann cells.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23552-8
- By:
- Publication type:
- Article
How should newer therapeutic agents be incorporated into the treatment of patients with myasthenia gravis?
- Published in:
- Muscle & Nerve, 2024, v. 69, n. 4, p. 389, doi. 10.1002/mus.28038
- By:
- Publication type:
- Article
The diagnosis of myasthenia gravis: The sensitive issue of specificity.
- Published in:
- Muscle & Nerve, 2023, v. 67, n. 6, p. 436, doi. 10.1002/mus.27814
- By:
- Publication type:
- Article
Re: Diagnosing myasthenia gravis in older patients: Comments and observations.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Validation of myasthenia gravis diagnosis in the older Medicare population.
- Published in:
- Muscle & Nerve, 2022, v. 65, n. 6, p. 676, doi. 10.1002/mus.27526
- By:
- Publication type:
- Article
Utilization of MG‐ADL in myasthenia gravis clinical research and care.
- Published in:
- Muscle & Nerve, 2022, v. 65, n. 6, p. 630, doi. 10.1002/mus.27476
- By:
- Publication type:
- Article
Iatrogenic immunodeficiency‐associated lymphoproliferative disorder secondary to mycophenolate mofetil treatment in a patient with myasthenia gravis.
- Published in:
- Muscle & Nerve, 2022, v. 65, n. 4, p. E14, doi. 10.1002/mus.27485
- By:
- Publication type:
- Article
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Burden of illness in patients with treatment refractory myasthenia gravis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cardiac involvement in the muscular dystrophies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Start high, then go low: An effective strategy in the treatment of myasthenia gravis.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Asymptomatic/pauci-symptomatic creatine kinase elevations (hyperckemia).
- Published in:
- Muscle & Nerve, 2013, v. 47, n. 6, p. 805, doi. 10.1002/mus.23755
- By:
- Publication type:
- Article
Knockout of PA200 improves proteasomal degradation and myelination in a proteotoxic neuropathy.
- Published in:
- Life Science Alliance, 2024, v. 7, n. 4, p. 1, doi. 10.26508/lsa.202302349
- By:
- Publication type:
- Article
Rituximab in Treatment-Refractory Myasthenia Gravis.
- Published in:
- JAMA Neurology, 2017, v. 74, n. 1, p. 21, doi. 10.1001/jamaneurol.2016.4367
- By:
- Publication type:
- Article
A dual role for Integrin α6β4 in modulating hereditary neuropathy with liability to pressure palsies.
- Published in:
- Journal of Neurochemistry, 2018, v. 145, n. 3, p. 245, doi. 10.1111/jnc.14295
- By:
- Publication type:
- Article
Corrigendum: Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.
- Published in:
- Human Molecular Genetics, 2019, v. 28, n. 13, p. 2282, doi. 10.1093/hmg/ddz037
- By:
- Publication type:
- Article
Corrigendum: Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.
- Published in:
- Human Molecular Genetics, 2019, v. 28, n. 10, p. 1752, doi. 10.1093/hmg/ddz021
- By:
- Publication type:
- Article
Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.
- Published in:
- Human Molecular Genetics, 2019, v. 28, n. 8, p. 1260, doi. 10.1093/hmg/ddy420
- By:
- Publication type:
- Article
Phase 2 trial in acetylcholine receptor antibody‐positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 5, p. 1417, doi. 10.1111/ene.15745
- By:
- Publication type:
- Article
Ablation of Perk in Schwann Cells Improves Myelination in the S63del Charcot-Marie-Tooth 1B Mouse.
- Published in:
- Journal of Neuroscience, 2016, v. 36, n. 44, p. 11350, doi. 10.1523/JNEUROSCI.1637-16.2016
- By:
- Publication type:
- Article
A new mouse model of Charcot-Marie-Tooth 2J neuropathy replicates human axonopathy and suggest alteration in axo-glia communication.
- Published in:
- PLoS Genetics, 2022, v. 18, n. 11, p. 1, doi. 10.1371/journal.pgen.1010477
- By:
- Publication type:
- Article